Skip to main content
OpenTrials
Completed

NCT Number: NCT05187962

Differential Sensory Block During Labor Epidural Analgesia: a Prospective Observational Study to Investigate the Relationship of Lower and Upper Sensory Block Levels to Cold With Sensory Block to Pinprick and Light Touch

Epidural analgesia remains the gold standard for pain control during labor and delivery. Proper assessment of an epidural's level of blockade is important for providing safe and effective analgesia. Previous studies have established that the most commonly tested modality for adequacy of epidural blockade is a patient's sensory blockade to cold temperature. In a study performed at our institution, Soares et. al. (publication pending) documented two thresholds of sensory block to ice: one defined as the lower sensory block level, in which the patient is able to notice the cold sensation but perceives that it is not as cold as a control dermatome; the other defined as the upper sensory block level, in which the patient perceives that the cold sensation is at approximately the same temperature as if it were applied to a non-anesthetized area such as the neck or face. Although this a known finding to nurses and physicians assessing the sensory block to ice, this phenomenon and its magnitude has not been previously reported in epidural anesthesia. The goal of this study is to examine patients with labour epidurals and to determine the dermatomal relationship between the lower and upper sensory block levels to cold when compared with sensory blockade to both pinprick and light touch.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

Female

Study type

Observational

Primary location

Mount Sinai Hospital

Toronto, Ontario, M5G1X5, Canada

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ASA Physical Status Classification II and III parturients
  • Requested and received a labour epidural
  • Capable of consenting to the study
  • Have no language barrier which may obfuscate the sensory block assessment
  • Are receiving programmed intermittent epidural boluses (PIEB) for maintenance analgesia, which is the Mount Sinai Hospital default maintenance regimen

Exclusion criteria

  • Medical comorbidities that could compromise the body's sensitivity to cold, pinprick, or touch
  • Epidurals performed under a combined spinal-epidural (CSE) or dural puncture epidural (DPE) technique
  • Epidurals with a documented unintentional dural puncture
  • Inadequate epidural analgesia requiring either manually administered epidural boluses, an increase in the concentration of their maintenance local anesthetic, or a repeat of their epidural

Treatment and study plan

Primary outcomes

  1. Lower sensory block level: ice test

    Time frame: 5 minutes

    The lower sensory block level to ice, defined as the dermatome at which there is a complete loss of cold perception.

  2. Upper sensory block level: ice test

    Time frame: 5 minutes

    The upper sensory block level to ice is defined as the dermatome at which there is an altered cold perception without complete sensitivity loss.

  3. Lower sensory block level: pinprick test

    Time frame: 5 minutes

    The lower sensory block level to pinprick, defined as the dermatome at which there is a complete loss of sharp sensation.

  4. Upper sensory block level: pinprick test

    Time frame: 5 minutes

    The upper sensory block level to pinprick is defined as the dermatome at which there is an altered sharp sensation without complete sensitivity loss.

  5. Sensory block level: soft touch test

    Time frame: 5 minutes

    The sensory block level using soft touch is defined as the dermatome below which the patient can feel a light touch.

Secondary outcomes

  1. Motor block score using Bromage score

    Time frame: 5 minutes

    Motor block will be assessed with the Bromage score: 0 = able to raise the extended leg; 1 = unable to raise the extended leg but able to flex knees; 2 = unable to flex knees, but able to flex ankle; 3 = unable to flex ankle.

Sponsors and collaborators

Lead sponsor

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

Other

Registry information

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Jan 12, 2022
Registry last updated
Oct 25, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.